⚠️ 35 settlements closing this week 1 day left →
🏢 Brand Settlements

Hetero Valsartan $11.37M Drug Class Action Settlements — 3 Active Cases

SettlementRadar is not affiliated with, endorsed by, or connected to Hetero Valsartan $11.37M Drug. This page provides independent information about class action settlements involving this company.

$26.57M Total Fund   2 no-proof settlements — file with no documentation required. Deadlines are approaching. Check eligibility now.

We'll File For You — $9.99 Get Hetero Valsartan $11.37M Drug Alerts →
⚖️
3
Active Cases
💵
$26.57M
Total Fund
✅
2
No Proof Required
📅
43d
Nearest Deadline

Open Hetero Valsartan $11.37M Drug Settlements

Healthcare ⏳ 42 days left 🟢 Easy ✓ No Proof

Hetero Valsartan $11.37M Drug Contamination Settlement

Consumers who bought Hetero Valsartan between May 1, 2018, and July 31, 2018, may be eligible to claim a cash payment from a class action settlement.

Who qualifies: Class members must meet all of the following criteria: They are an individual in the United States, its territories or possessions. They paid any amou
$11,370,000
Total settlement fund
Consumer ⏳ 42 days left 🟢 Easy ✓ No Proof

Valsartan, Losartan, Irbesartan

You may be included in this settlement if you paid for Hetero Valsartan, Aurobindo Irbesartan, or Vivimed Losartan medications between January 1, 2016 and the present.

Who qualifies: You may be included in this settlement if you paid for Hetero Valsartan, Aurobindo Irbesartan, or Vivimed Losartan medications between January 1, 2016
Consumer ⏳ 42 days left 🟡 Medium

$15.2M Valsartan, Losartan and Irbesartan class action settlement

Aurobindo, Hetero and Vivimed agreed to settlements totaling more than $15.2 million over claims their blood pressure medications were contaminated with cancer-causing substances.

Who qualifies: The Aurobindo settlement benefits consumers who paid for irbesartan medications manufactured with Aurobindo irbesartan active pharmaceutical ingredien
$40 — $200
Est. payout per person

Frequently Asked Questions

Is there a class action lawsuit against Hetero Valsartan $11.37M Drug? +
Yes. SettlementRadar is tracking 3 active class action settlements involving Hetero Valsartan $11.37M Drug. 2 of these require no proof to file. You may be eligible to file a claim and receive a cash payment.
How do I file a Hetero Valsartan $11.37M Drug settlement claim? +
Click "Check Eligibility" on any settlement above to review the requirements and file online. Most Hetero Valsartan $11.37M Drug claims take under 5 minutes. For $9.99, SettlementRadar will complete and submit all Hetero Valsartan $11.37M Drug claim paperwork for you.
Is Hetero Valsartan $11.37M Drug still paying settlements? +
Yes — 3 active cases are currently open for claims. The nearest deadline is in 43 days, so act quickly. Missing a deadline forfeits your right to compensation.
How much will I get from a Hetero Valsartan $11.37M Drug settlement? +
The Hetero Valsartan $11.37M Drug settlement fund totals $26.57M. Individual payouts depend on the settlement and how many people file claims. Check each settlement card above for estimated per-person payout ranges.
What is the deadline to file a Hetero Valsartan $11.37M Drug settlement claim? +
Deadlines vary by case. Check the countdown timers on each settlement card above. The soonest Hetero Valsartan $11.37M Drug deadline is in 43 days. Sign up for alerts below to be notified before deadlines pass.

Other Companies with Active Settlements

SouthState Bank (5) Class Action (4) Joint Juice (4) Cardiovascular Consultants (3) Comcast (3) Akeela (2) Balance Autism (2) Boohoo - Advertised Sales (2) Box (2) CSC ServiceWorks (2) Complete Payroll Solutions (2) Concord Orthopaedics (2) View all brands →
Comparing